<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> (AA) and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are marrow failure states that may be associated with <z:mp ids='MP_0008866'>chromosomal instability</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>An absence of the <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase (GST) enzyme may genetically predispose individuals to AA or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>PROCEDURE AND RESULTS: To test this hypothesis, we determined the GSTM1 and GSTT1 genotypes in a total of 196 patients using multiplex PCR </plain></SENT>
<SENT sid="3" pm="."><plain>The GSTT1 null genotype was found to be overrepresented in Caucasian, Asian, and Hispanic patients with either AA or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We confirmed a difference in the expected frequency of the GSTM1 null genotype in Caucasian <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="5" pm="."><plain>The double null GSTM1/GSTT1 genotype was also overrepresented in Caucasian AA and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="6" pm="."><plain>In our population, 26% of AA patients and 40% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients had a chromosomal abnormality identified by karyotype or FISH analyses for chromosomes 7 and 8 </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with AA and the GSTT1 null genotype had an increased frequency of chromosomal abnormalities (P = 0.003) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: There seems to be an increased risk for AA and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in individuals lacking GSTT1 or both GSTM1/GSTT1 </plain></SENT>
</text></document>